{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"79"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"292"}],"units":"Participants"}],"description":"Grade III-IV graft versus host disease","groups":[{"description":"Patients with refractory leukemia or MDS","id":"OG000","title":"High Risk Patients"},{"description":"Patients with Disease criteria: Acute myelogenous leukemia , Acute lymphocytic leukemia, Chronic myelogenous leukemia , NHL, Hodgkins, chronic lymphocytic leukemia, multiple myeloma, Acquired bone marrow failure syndromes, Myelodysplastic syndrome, Renal cell cancer,Chronic myeloproliferative disorder","id":"OG001","title":"Standard Risk Patients"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Day 100","title":"Acute Graft-Versus-Host Disease","type":"SECONDARY","unitOfMeasure":"Participants"}